Frances is an intellectual property attorney whose practice is focused on patent matters. She works with clients in a wide variety of industries, including life sciences.
While earning her JD, Frances worked as a summer associate at an international law firm. She was a Stanback Fellow at Duke Law’s Environmental Law and Policy Clinic, and served as a staff editor of the Duke Environmental Law & Policy Forum and the Duke Law & Technology Review while earning her JD.
As an undergraduate, Frances assisted with evolutionary genomics research characterizing Caulobacter strains and the bacteriophage that infect them.
viewpoints
Supreme Court Clarifies Standard for Induced Infringement in Hikma v. Amarin
June 4, 2026 | Blog | By Siegmund Gutman, T.O. Kong, David Hanna, Rich Gervase, Adam Samansky, Peter Cuomo, Daniela Glaser, Frances Senn
In a unanimous decision handed down today, the Supreme Court delivered a tactical victory for Hikma, and a measure of guidance for other generic manufacturers. In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, the Court held that drug manufacturer Amarin, the reference product sponsor, failed to state a claim for active inducement of patent infringement under 35 U.S.C. § 271(b).
Recent Insights
